Next Article in Journal
Asymmetric Synthesis of Spirocyclic 2-Benzopyrans for Positron Emission Tomography of σ1 Receptors in the Brain
Next Article in Special Issue
Mercury-Supported Biomimetic Membranes for the Investigation of Antimicrobial Peptides
Previous Article in Journal
Ritonavir-Mediated Induction of Apoptosis in Pancreatic Cancer Occurs via the RB/E2F-1 and AKT Pathways
Open AccessReview

Host-Defense Peptides with Therapeutic Potential from Skin Secretions of Frogs from the Family Pipidae

Department of Biochemistry, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain 17666, UAE
*
Author to whom correspondence should be addressed.
Pharmaceuticals 2014, 7(1), 58-77; https://doi.org/10.3390/ph7010058
Received: 9 December 2013 / Revised: 7 January 2014 / Accepted: 8 January 2014 / Published: 15 January 2014
Skin secretions from frogs belonging to the genera Xenopus, Silurana, Hymenochirus, and Pseudhymenochirus in the family Pipidae are a rich source of host-defense peptides with varying degrees of antimicrobial activities and cytotoxicities to mammalian cells. Magainin, peptide glycine-leucine-amide (PGLa), caerulein-precursor fragment (CPF), and xenopsin-precursor fragment (XPF) peptides have been isolated from norepinephrine-stimulated skin secretions from several species of Xenopus and Silurana. Hymenochirins and pseudhymenochirins have been isolated from Hymenochirus boettgeri and Pseudhymenochirus merlini. A major obstacle to the development of these peptides as anti-infective agents is their hemolytic activities against human erythrocytes. Analogs of the magainins, CPF peptides and hymenochirin-1B with increased antimicrobial potencies and low cytotoxicities have been developed that are active (MIC < 5 μM) against multidrug-resistant clinical isolates of Staphylococcus aureus, Escherichia coli, Acinetobacter baumannii, Stenotrophomonas maltophilia and Klebsiella pneumoniae. Despite this, the therapeutic potential of frog skin peptides as anti-infective agents has not been realized so that alternative clinical applications as anti-cancer, anti-viral, anti-diabetic, or immunomodulatory drugs are being explored. View Full-Text
Keywords: frog skin; magainin; PGLa; caerulein-precursor fragment; xenopsin-precursor-fragment; hymenochirin frog skin; magainin; PGLa; caerulein-precursor fragment; xenopsin-precursor-fragment; hymenochirin
Show Figures

Figure 1

MDPI and ACS Style

Conlon, J.M.; Mechkarska, M. Host-Defense Peptides with Therapeutic Potential from Skin Secretions of Frogs from the Family Pipidae. Pharmaceuticals 2014, 7, 58-77.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop